Save the date! We are presenting at the 27th Annual @American Society of Gene & Cell Therapy (#ASGCT) Meeting next week in Baltimore, MD!

📌 Abstract Title: S/MAR-Containing AAV Vectors Result in an Increase in AVV Episomes & a Reduction in AAV Integration Sites in a Mouse Model with a High Rate of Hepatocyte Proliferation

🗓️ Date: Friday, May 10, 202

🕒 Time: 13:00-13:45 EDT

📍 Oral Abstract Session: AAV Vectors – Preclinical and Proof-of-Concept In-Vivo Studies (Excluding Non-Human Primates)

🔍 Abstract Number: 247

🏢 Location: Ballroom 2

Presenter: @Andrea Llanos-Ardaiz, PhD of @Vivet Therapeutics

Reach out if you would like to meet with CEO @Jean-Philippe Combal, CSO @Gloria Gonzalez-Aseguinolaza and Senior Project Leader @Veronica Ferrer who will also be in attendance from 7-11 May.

#Vivet is dedicated to creating gene therapies for rare inherited liver metabolic disorders, with long lasting therapeutic benefit. To learn more about Vivet’s disruptive development engine and its diversified pipeline, use the link in the first comment below!